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Background/Objectives: Pseudomonas and Klebsiella infections are important nosocomial infections because of the 
attendant significant morbidity, mortality and socio-economic impact. These infections are difficult to treat due to the 
innate and acquired resistance mediated by the organisms’ genome and other transferable genetic elements. We determined 
the multiple antibiotic resistance indices of Pseudomonas spp and Klebsiella spp isolated from clinical specimens in Lagos 
University Teaching Hospital.  
Methods:  110 clinical isolates were evaluated using MicrobactTM 24E (Oxoid, UK) and Pseudomonas and Klebsiella species 
isolates were 34 and 21 respectively. The antimicrobial susceptibility patterns of the Pseudomonas and Klebsiella isolates 
were determined by Kirby-Bauer’s disc diffusion method and results interpreted by CLSI interpretative values. Multiple 
Antibiotic Resistance index (MAR) were calculated. 
 Results: MAR index of the Pseudomonas and Klebsiella samples was 0.4, as 31 (91.2%) and 14 (66.7%) of Pseudomonas spp 
and Klebsiella spp respectively were multi drug resistant. Isolates of Pseudomonas spp demonstrated the highest level of 
resistance to Ceftazidime (79.4%), Cefixime (76.5%), Cedipime (50%) and Piperacillin (44.1%); while that of Klebsiella spp 
were carbenicillin (76.4%), pipericillin (71.4%), cefixime (52.4%) and cefradoxil (42.9%) respectively. There was a low level 
of resistance to quinolones and aminoglycosides.  
Conclusion: The MAR index shows increase in the rates of resistance among these organisms thus making antimicrobial 
susceptibility surveillance and testing more crucial in selecting empiric regimen or definitive treatment. 
 
KEY WORDS: Lagos, multiple antibiotic resistance (MAR), antimicrobial susceptibility, Pseudomonas and Klebsiella spp. 
 
INTRODUCTION: 
The World Health Organization (WHO) estimated 
that infections accounted for 45% of deaths in Africa 
and South-East Asia and were responsible for 48% 
of premature deaths worldwide, bacterial infection 
accounted for a significant proportion of these 
infections in Africa [1]. The valuable life spans of 
most antibiotics used in treating these infections 
have been diminished by the development of 
resistant strains. Microorganisms use a combination 
of mechanisms in developing resistance however a 
dominant mechanism may be identifiable [2,3]. The 
relationship between antibiotic use and resistance is 
complex; a major driving factor for antibiotic 
resistance is antibiotic use/abuse both within 
medicine and veterinary medicine. In Nigeria 53% 
of respondents in a survey took incomplete regimen 
of antibiotics, a significant proportion of which 
were self prescribed for unspecified ailments [4,5]. 
 
Antibiotic resistance increasingly compromises the 
outcome of many infections that were, until 
recently, treatable and remain the most common 
diseases in Africa [6].  The global problem of 
antimicrobial resistance is particularly pressing in 
developing countries, where the infectious disease 
burden is high and cost constraints prevent the 
widespread application of newer, more expensive 
agents [6]. Reports from multiple studies from  
 
 
different parts of Nigeria though have observed 
temporal trends in the prevalence of resistance 
among enteric organisms have shown increasing 
prevalence in the last fifteen years [7].  
 
High prevalence of multidrug resistance indicates a 
serious need for broad-based, local antimicrobial 
resistance surveillance and planning of effective 
interventions to reduce multidrug resistance in such 
pathogens [8]. Multiple antibiotic resistance (MAR) 
in bacteria is most commonly associated with the 
presence of plasmids which contain one or more 
resistance genes, each encoding a single antibiotic 
resistance phenotype [9].  
 
Emergence of antibiotic resistance in P. aeruginosa 
resulting in severe adverse outcomes had been on 
the rise. In the USA annual prevalence of 
fluoroquinolones and imipenem resistant P. 
aeruginosa   increased from 15% in 1991 to 41% in 
2000 1%, and from 1989 to 2006 from 13% to 20% 
respectively [10]. In Lagos, similar results have been 
previously documented [11]. These same 
conclusions had been drawn in Zaria though P. 




fluoroquinolones [9]. In Zaria and Enugu about 60 
% , 42%, 33% of  clinical isolates of Pseudomonas spp, 
Escherichia spp, and Klebsiella spp respectively were 
noted to be multidrug resistant [12]. In Enugu and 
Abakaliki 62% of Klebsiella isolates were ESBL 
producers.  
 
Multiple antibiotic resistance (MAR) indexing has 
been shown to be a cost effective and valid method 
of bacteria source tracking. Multiple antibiotic 
resistance index is calculated as the ratio of number 
of resistant antibiotics to which organism is 
resistant to total number of antibiotics to which 
organism is exposed [13, 14]. MAR index values 
greater than 0.2 indicate high risk source of 
contamination where antibiotics are often used. 
This study was carried out to evaluate the MAR 
indexes values of clinical isolates of Pseudomonas spp 




Pre-identified clinical isolates of gram negative 
bacilli species (110 in number) were obtained from 
Lagos University Teaching Hospital (LUTH) 
Microbiology laboratory between June and 
September 2010 and preserved on nutrient agar for 
further identification. Isolates sub-cultured from 
nutrient agar slants onto MacConkey agar medium 
were identified by a combination of colonial 
morphological characteristics, gram stain, and 
motility. Further biochemical characterisation was 
done using MicrobactTM 24E (Oxoid, UK). 
Antimicrobial susceptibility pattern of the isolates 
were done after they were re-identified. 
Antimicrobial susceptibility testing was performed 
using the disc diffusion method (Bauer et al 1966). 
Antibiotic discs tested were Cefixime, Cedipime, 
Cefradoxil, Ceftazidime, Cefuroxime, Gentamycin, 
Amikacin, Piperacillin, Carbenicillin, Ciprofloxacin, 
Ofloxacin, Imipenem (Oxoid, UK)  
 
Values obtained were interpreted according to the 
Clinical and Laboratory standards Institute (CLSI, 
2010) into resistant, intermediate and sensitive 
categories. Apart from general caution to strictly 
follow procedures as described in manufacturer’s 
manual, Pseudomonas aeruginosa ATCC 2785 and 
Escherichia coli ATCC 25922 were used as positive 
and negative controls respectively.  
MAR index was determined by following the 
procedure described by Krumperman 1983 [14]. A 
MAR index for an isolate is calculated as: Number 
of antibiotics to which isolate is resistant/                                   




Total no of clinical isolates obtained from LUTH 
laboratory was 110. Morphological and biochemical 
identification revealed that 34 (30.9%) of these were 
Pseudomonas species while 21(19.1%) and 22 (20%) 
were Klebsiella and Escherichia species. The rest 
33(30%) were made up by a diverse group of the 
family Enterobacteriacae namely Serratia, 
Acinetobacter, Enterobacter, Acetobacter and Citrobacter 
species. 
 
Overall antibiotics prescribed by physicians 
working in all units in LUTH in order of 
descending frequency included 
Ampicillin/Cloxacillin, Amoxicillin/Clavulanic 
acid, Gentamycin, Ciprofloxacin, Cefuroxime, 
Ceftazidime, Ceftriaxone, Pefloxacin, Ofloxacin, 
Imipenem.  
The total proportion of isolates found sensitive to 
all antibiotics used in antimicrobial susceptibility 
testing in Pseudomonas and Klebsiella spp were 58.4% 
and 52.2% respectively. 
 
Table 1 and figure 1 show the resistance pattern of 
Pseudomonas to each antibiotic used in the 
antimicrobial susceptibility testing. Ceftazidime 27 
(79.4%) demonstrated the highest levels of 
resistance followed by Cefixime 26 (76.5%) while 
other cephalosporins demonstrated moderate 
activity against Pseudomonas.  Isolates were most 
sensitive to Imipenem 32 (94.15), Genticin 31 
(91.2%), and Ciprofloxacin 29 (85.3%). 76.5 % of 
isolates were sensitive to Ofloxacin and Amikacin. 
Nearly all isolates 31(91.2%) had Multiple 
Antibiotic Resistance (MAR) index that was higher 
0.2 only 3 (8.8%) had a MAR of 0.2 or less. MAR 
index of the Pseudomonas sample is 0.4. 
 
Table 2 shows the resistance pattern of Klebsiella to 
each antibiotic used in the antimicrobial 
susceptibility testing. The highest levels of 
resistance were seen in Piperacillin and Ceftazidime 
15 (71.4%); other cephalosporin’s also demonstrated 
high levels of resistance. Isolates were most 
sensitive to Imipenem 20 (95.2%) followed by 
Gentamycin 19 (90.5%), Ciprofloxacin 19 (90.5%) 
and Cedipime 18 (85.7%) respectively. Ofloxacin 
and Amikacin were moderately active against 
Klebsiella isolates. Only a third of the isolates were 
resistant to two or less antibiotics. The proportion of 
isolates with Multiple Antibiotic Resistance (MAR) 
index greater than 0.2 was 66.7% (14) while those 
with MAR index less than 0.2 was 33.3% (7) 
showing that a greater proportion of the isolates are 
likely to be from a high risk source.  The MAR 
index of the Klebsiella sample was 0.4. 
Figures 1 &2 demonstrate the comparative 
sensitivity pattern of Pseudomonas and Klebsiella 











Antibacterial Agent   n  %S  %I  %R 
Cefixime                CFM  34  17.7  5.9  76.5 
          Cedipime           FEP            34           47.1            2.9            50 
Cefradoxil  CFR  34  50  2.9  47.1 
Ceftazidime  CA2  34  17.7  2.9  79.4 
Cefuroxime  CXM  34  85.3  2.9  11.8 
Imipenem  IPM  34  94.1  0  5.9 
Piperacillin  PRL  34  55.9  0  44.1 
Carbenicillin  CAR  34  58.8  5.9  35.3 
Ciprofloxacin  CIP  34  85.3  0  14.7 
          Ofloxacin            OFX            34            76.5            5.9            17.7 
Gentamycin  GN  34  91.2  2.9  5.9 
           Amikacin             AK              34             76.5            8.8            14.7 
n = no of isolates, S = sensitive, I – intermediate, R = resistant (according to CLSI 
 
TABLE 2: ANTIMICROBIAL SUSCEPTIBILITY TESTING BY DISC DIFFUSION METHOD FOR KLEBSIELLA ISOLATES 
        Susceptibility Rates 
Antibacterial Agent   n  %S  %I  %R 
 
Cefixime   CFM  21  38.1  4.8  52.4 
Cedipime  FEP  21  85.7  4.8  9.5 
Cefradoxil  CFR  21  38.1  19  42.9 
Ceftazidime  CA2  21  61.9  0  38.1 
Cefuroxime  CXM  21  47.6  28.6  23.8 
Imipenem  IPM  21  95.2  0  4.8 
Piperacillin  PRL  21  28.6  0  71.4 
Carbenicillin  CAR  21  9.5  48  76.4 
Ciprofloxacin  CIP  21  90.5  0  9.5  
Ofloxacin  OFX  21  61.9  0  38.1 
Gentamycin  GN  21  90.5  0  9.5 
Amikacin  AK  21  57.1  14.3  28.6 
 













FIGURE 1: COMPARISON OF SENSITIVITY PATTERN OF                                                                               
PSEUDOMONAS ISOLATES TO IMIPENEM, GENTICIN,                                                                                
CIPROFLOXACIN AND CEFTAZIDIME. 
Blue bars represent proportion that is sensitive;





High prevalence of multidrug resistance indicate
serious need for antibiotics surveillance program. 
Multiple antibiotic resistance (MAR) analysis has 
been used to differentiate bacteria from different  
sources  using  antibiotics  that  are  commonly used  
for  human  therapy. Compared to other metho
bacteria source tracking such as genotypic 
characterization, the MAR indexing method is cost
effective, rapid and easy to perform.  It is also 
simple and does not require specialized training 
and expensive equipment [13]. The monitoring of 
both antibiotic consumption and multiple antibiotic 
resistances (MAR) especially in nosocomial 
infections is critically necessary to setting up of 
effective containment programs and audit of such 
programs [13, 15]. 
 
Pseudomonas and Klebsiella are major pathogens in 
healthcare associated infections (HAI)[12]. This not 
only because of the attendant significant morbidity 
associated with infections but also because 
increasing rates of resistance in them is making it 
more difficult for them to be treated with cheaper 
first line antibiotics. Emerging and increasing 
resistance to newer and otherwise efficacious 
antibiotics may compound the whole problem[1]. 
The 30.9% and over 19% prevalence obtained for 
pseudomonas and klebsiella respectively out of a 
sample of 110 clinical isolates approximate to 
prevalence previously obtained in centre of study 

































        
       
 
                                                                                                                             
 
FIGURE 2: COMPARISON OF SENSITIVITY PATTERN                                                                                  
OF KLEBSIELLA ISOLATES TO IMIPENEM, GENTICIN,                        
CIPROFLOXACIN AND CEFTAZIDIME. 
Blue bars represent proportion that is sensitive; 




Isolates of both genera demonstrated high levels of 
susceptibility to the first three drugs (imipenem 32 
(94.15%), genticin 19 (91.2%) and ciprofloxacin 29 
(85.3%) for pseudomonas and imipenem 
Genticin 19 (90.5%), Ciprofloxacin 19 (90.5%) for 
klebsiella spp while varying levels of resistance from 
moderate to high levels resistance were 
demonstrated to the cephalosporins. This finding is 
consistent with that of other studies which reported 
low resistance profiles for the quinolones and 
aminoglycosides respectively[8, 12, 16]. However 
the difference in resistance rates in these works may 
be (in spite of general similar low rates profile for 
these drugs) explained by the increasing trend that 
had been noted globally [1]. This may have 
implications on the effectiveness of the local and 
probably national hospital infection and antibiotic 
resistance control programs. The moderate to high 
levels of resistance in the cephalosporins 
underscore the emergence of 
specifically cephalosporinases among resistant 
strains of these organisms as previously reported 
[2,6,10.14.15]. This compromises the clinical efficacy 
of a very important class of drugs commonly used 
in the management of many infections in this 
environment. The clearly visible high rate
resistance of isolates to penicillin (Piperacillin, 
Carbenicillin) corroborates documented increasing 
penicillinase-producing B-lactamases
these organisms [10]. 
 
Analysis of the MAR index of isolates showed that 


























                     
                                                                         
 










isolates were resistant to three or more antibiotics. 
These figures were higher than was seen in the 
series done by Olayinka et al. This may be due to 
either the difference in the definition used for 
multidrug resistance in both works or may be an 
indication of a significant jump in the emergence of 
multi-drug resistance strains. Olayinka et al in their 
series estimated their proportion on the basis of 
resistance to four drugs or more. Three was used in 
this study as it approximates more with the general 
definition of multi-drug resistance [2]. 
 All these findings have implications for the choice 
of antibiotics for empiric management of infections, 
continuous surveillance of antibiotic susceptibility 
patters and effective hospital infection control. 
Bacterial strains resistant to most classes of 
antibiotics will continue to emerge unless 
inappropriate uses of drugs are curtailed and 
continuous education of infection control practices 
maintained.   
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